* Shattuck Labs Inc reported a quarterly adjusted loss of 41 cents per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -60 cents. The mean expectation of five analysts for the quarter was for a loss of 57 cents per share. Wall Street expected results to range from -68 cents to -51 cents per share.
* Revenue rose 83.1% to $714.00 thousand from a year ago; analysts expected $202.00 thousand.
* Shattuck Labs Inc's reported EPS for the quarter was a loss of 41 cents.
* The company reported a quarterly loss of $17.69 million.
* Shattuck Labs Inc shares had risen by 26.1% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 0.5% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for Shattuck Labs Inc is $12.00 This summary was machine generated from LSEG data February 29 at 10:55 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.57 -0.41 Beat
Sep. 30 2023 -0.52 -0.65 Missed
Jun. 30 2023 -0.52 -0.50 Beat
Mar. 31 2023 -0.63 -0.49 Beat
Comments